Comparative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccination in Community-Dwelling Veterans

Clinical Infectious Diseases

Volumn 61, Issue 2, 2015, Pages 171-176

  Richardson, Diane M ^a   Medvedeva, Elina L ^a   Roberts, Christopher B ^a   Linkin, Darren R ^b,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

comparative effectiveness research; elderly; influenza human; influenza vaccines

Indexed keywords

INFLUENZA VACCINE; INACTIVATED VACCINE;

ADULT; AGED; ARTICLE; COMPARATIVE EFFECTIVENESS; DRUG MEGADOSE; FEMALE; HEALTH CARE MANAGEMENT; HOSPITALIZATION; HUMAN; INFECTION RISK; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OUTCOME ASSESSMENT; PNEUMONIA; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEASONAL INFLUENZA; TREATMENT OUTCOME; VETERAN; AGE; COHORT ANALYSIS; COMPARATIVE STUDY; IMMUNOLOGY; INFLUENZA, HUMAN; MORTALITY; RISK; SEASON; STATISTICS AND NUMERICAL DATA; VACCINATION; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; COHORT STUDIES; COMPARATIVE EFFECTIVENESS RESEARCH; FEMALE; HOSPITALIZATION; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; PNEUMONIA; RETROSPECTIVE STUDIES; RISK; SEASONS; VACCINATION; VACCINES, INACTIVATED; VETERANS;

EID: 84936770375     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/civ261     Document Type: Article

References (31)

1. ThompsonWW, Shay DK,Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003; 289:179-86.
2. Thompson WW, Shay DK, Weintraub E, et al. Influenza-associated hospitalizations in the United States. JAMA 2004; 292:1333-40.
3. Simonsen L, Reichert TA, Viboud C, Blackwelder WC, Taylor RJ, Miller MA. Impact of influenza vaccination on seasonal mortality in the US elderly population. Arch Intern Med 2005; 165:265-72.
4. Widmer K, Zhu Y, Williams JV, Griffin MR, Edwards KM, Talbot HK. Rates of hospitalizations for respiratory syncytial virus, human metapneumovirus, and influenza virus in older adults. J Infect Dis 2012; 206:56-62.
5. Zhou H, ThompsonWW, Viboud CG, et al. Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008. Clin Infect Dis 2012; 54:1427-36.
6. Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis 2012; 12:36-44.
7. Jefferson T, Rivetti D, Rivetti A, Rudin M, Di Pietrantonj C, Demicheli V. Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review. Lancet 2005; 366:1165-74.
8. Baxter R, Ray GT, Fireman BH. Effect of influenza vaccination on hospitalizations in persons aged 50 years and older. Vaccine. 2010; 28: 7267-72.
9. Treanor JJ, Talbot HK, Ohmit SE, et al. Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains. Clin Infect Dis 2012; 55:951-9.
10. Kwong JC, Campitelli MA, Gubbay JB, et al. Vaccine effectiveness against laboratory-confirmed influenza hospitalizations among elderly adults during the 2010-2011 season. Clin Infect Dis 2013; 57: 820-7.
11. Poland GA, Mulligan MJ. The imperative of influenza vaccines for elderly individuals-an evolving story. J Infect Dis 2009; 200: 161-3.
12. US Food and Drug Administration. Fluzone High Dose Approval Letter. Available at: http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ ApprovedProducts/ucm195481.htm. Accessed 8 April 2015.
13. Falsey AR, Treanor JJ, Tornieporth N, Capellan J, Gorse GJ. Randomized, double?blind controlled phase 3 trial comparing the immunogenicity of high?dose and standard?dose influenza vaccine in adults 65 years of age and older. J Infect Dis 2009; 200:172-80.
14. DiazGranados CA, Dunning AJ, Kimmel M, et al. Efficacy of high-dose versus standard-dose influenza vaccine in older adults. N Engl J Med 2014; 371:635-45.
15. Centers for Disease Control and Prevention (CDC). Prevention and control of seasonal influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices-United States, 2013-2014. MMWR Recomm Rep 2013; 62(RR-07):1.
16. US Department of Veterans Affairs, VA Information Resource Center. Information about VA data. Available at: http://www.virec.research.va. gov/Resources/Info-About-VA-Data.asp. Accessed 7 December 2014.
17. Infectious Diseases Society of America. Medicare immunization billing, 2011. Available at: http://www.idsociety.org/uploadedFiles/IDSA/ Manage-Your-Practice/Forms-and-Documents/qr-immun-bill.pdf. Accessed 7 December 2014.
18. Centers for Disease Control and Prevention. WHO/NREVSS regional map 2010-2011. Available at: http://www.cdc.gov/flu/weekly/regions2010-2011/hhswhousmaps.htm. Accessed 7 December 2014.
19. Fireman B, Lee J, Lewis N, Bembom O, van der Laan M, Baxter R. Influenza vaccination and mortality: differentiating vaccine effects from bias. Am J Epidemiol 2009; 170:650-6.
20. Jackson ML, Weiss NS, Nelson JC, Jackson LA. To rule out confounding, observational studies of influenza vaccine need to include analyses during the "preinfluenza period." Arch Intern Med 2007; 167:1553-4; author reply 1554-5.
21. Gross PA, Russo C, Dran S, Cataruozolo P, Munk G, Lancey SC. Time to earliest peak serum antibody response to influenza vaccine in the elderly. Clin Diagn Lab Immunol 1997; 4:491-2.
22. van Walraven C, Austin PC, Jennings A, Quan H, Forster AJ. A modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data. Med Care 2009; 47:626-33.
23. Simonsen L, Taylor RJ, Viboud C, Miller MA, Jackson LA. Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect Dis 2007; 7:658-66.
24. Austin PC. The relative ability of different propensity score methods to balance measured covariates between treated and untreated subjects in observational studies. Med Decis Making 2009; 29:661-77.
25. Rosenbaum PR, Rubin DB. Reducing bias in observational studies using subclassification on the propensity score. J Am Stat Assoc 1984; 79:516-24.
26. Nelson JC, Jackson ML,Weiss NS, Jackson LA. New strategies are needed to improve the accuracy of influenza vaccine effectiveness estimates among seniors. J Clin Epidemiol 2009; 62:687-94.
27. Kent DM, Rothwell PM, Ioannidis JP, Altman DG, Hayward RA. Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal. Trials 2010; 11:85.
28. Centers for Disease Control and Prevention (CDC). Update: influenza activity-United States, 2010-11 season, and composition of the 2011-12 influenza vaccine. MMWR Morb Mortal Wkly Rep 2011; 60:705-12.
29. Tsang P, Gorse GJ, Strout CB, et al. Immunogenicity and safety of Fluzone intradermal and high-dose influenza vaccines in older adults ?65 years of age: a randomized, controlled, phase II trial. Vaccine. 2014; 32:2507-17.
30. DiazGranados CA, Dunning AJ, Jordanov E, Landolfi V, Denis M, Talbot HK. High-dose trivalent influenza vaccine compared to standard dose vaccine in elderly adults: safety, immunogenicity and relative efficacy during the 2009-2010 season. Vaccine 2013; 31:861-6.
31. Talbot HK, Griffin MR, Chen Q, Zhu Y, Williams JV, Edwards KM. Effectiveness of seasonal vaccine in preventing confirmed influenza-associated hospitalizations in community dwelling older adults. J Infect Dis 2011; 203:500-8.